Company / Total Assets
CHINA PHARMA HOLDINGS, INC. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$31.0M
FY2025
5-year range
$14.9M / $31.0M
FY2021-FY2025
Trend
+108.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 3 years of decline, reaching $31M.
Based on SEC 10-K filings.
$31M in FY2025 with a 5-year CAGR of +8.0%.
Improved from $16M to $31M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +20.3%
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +8.0%, indicating consistent growth.
- In FY2025, total assets increased 108.2% year-over-year.
- Peak total assets was recorded in FY2016.
- Lowest total assets in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $31.0M | +108.2% |
| FY2024 | $14.9M | -9.6% |
| FY2023 | $16.5M | -7.4% |
| FY2022 | $17.8M | -21.5% |
| FY2021 | $22.6M | +7.3% |
| FY2020 | $21.1M | -5.0% |
| FY2019 | $22.2M | -51.0% |
| FY2018 | $45.4M | -24.3% |
| FY2017 | $60.0M | -23.6% |
| FY2016 | $78.5M | -19.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026